Market Cap (In HKD)
5.47 Billion
Revenue (In HKD)
538.65 Million
Net Income (In HKD)
-373.09 Million
Avg. Volume
1.38 Million
- Currency
- HKD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 9.7-55.0
- PE
- -11.59
- EPS
- -0.66
- Beta Value
- 0.0
- ISIN
- CNE100006BL7
- CUSIP
- -
- CIK
- -
- Shares
- 716338422.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Dr. Jianyu Yang
- Employee Count
- -
- Website
- https://www.concordmedical.com
- Ipo Date
- 2024-01-09
- Details
- Concord Healthcare Group Co., Ltd. provides oncology healthcare service for cancer patients and medical institutions in China. It also offers oncology-related services, including sales and installing of medical equipment and software; management and technical support; and operating lease services. The company was incorporated in 2008 and is headquartered in Beijing, China. Concord Healthcare Group Co., Ltd operates as a subsidiary of Shanghai Medstar Financial Leasing Company.
More Stocks
-
ADF
-
ASSF
-
0RG7VP Bank AG
0RG7
-
DUTV
-
PSHG
-
HEAL
-
WFHG
-
NATURALNatural Biocon (India) Limited
NATURAL